Evidence map›Paper›PMID 28585320›Full record

ArticleBritish journal of pharmacology2017

Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine.

Linda D Simmler, Allison M J Anacker, Michael H Levin, Nina M Vaswani, Paul J Gresch, Alex G Nackenoff, Noelle C Anastasio, Sonja J Stutz, Kathryn A Cunningham, Jing Wang and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Substance Addiction Rehabilitation Drugs.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Differential genetic expression within reward-specific ensembles in mice.bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Linda D SimmlerDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Allison M J AnackerDepartment of Psychiatry, Columbia University; New York State Psychiatric Institute, New York, NY, USA.
Michael H LevinDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Nina M VaswaniDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Paul J GreschDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Alex G NackenoffDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Noelle C AnastasioCenter for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA.
Sonja J StutzCenter for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA.
Kathryn A CunninghamCenter for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA.
Jing WangDepartment of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Bing ZhangDepartment of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA.
L Keith HenryDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA.
Adele StewartDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Jeremy Veenstra-VanderWeeleDepartment of Psychiatry, Columbia University; New York State Psychiatric Institute, New York, NY, USA.
Randy D BlakelyDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-2182-6966
Vanderbilt University · USAllen Institute for Brain Science · USThe University of Texas Medical Branch at Galveston · USBaylor College of Medicine · USNew York Psychoanalytic Society and Institute · USUniversity of North Dakota · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The role of class IIa Hdac in regulating cell fate choice in early cortical development.P20GM104360 · NIGMS · UNIVERSITY OF NORTH DAKOTA · PI ROCHE, BENJAMIN · 2013 to 2023
$21.1M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI HARRELL, FRANK E. · 1985 to 2014
$18.6M
Translational Research Training in Child PsychiatryT32MH016434 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Cristiane S. Duarte, Kate Dimond Fitzgerald · 1985 to 2026
$10.9M
Stress-Mediated Alterations in Serotonin 2C Receptor Editing and FunctionP50MH096972 · NIMH · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2012 to 2016
$10.5M
VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced GenomicsG20RR030956 · NCRR · VANDERBILT UNIVERSITY · PI PIETENPOL, JENNIFER A · 2010 to 2010
$8.7M
Program in NeurogenomicsT32MH065215 · NIMH · VANDERBILT UNIVERSITY · PI ROGER J COLBRAN · 2002 to 2026
$6.4M
Regulation of Serotonin TransportersR01MH094527 · NIMH · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2011 to 2021
$4.4M
Neurobiological Signatures of Social Dysfunction and Repetitive BehaviorR01MH094604 · NIMH · VANDERBILT UNIVERSITY · PI VEENSTRA-VANDERWEELE, JEREMY · 2011 to 2015
$2.0M
Addiction and the Neuropharmacology of PsychostimulantsK05DA020087 · NIDA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI CUNNINGHAM, KATHRYN A. · 2005 to 2015
$1.3M
NCI NIH HHS P30 CA068485NCRR NIH HHS G20 RR030956NCRR NIH HHS UL1 RR024975NEI NIH HHS P30 EY008126NICHD NIH HHS P30 HD015052NIDA NIH HHS K05 DA020087NIGMS NIH HHS P20 GM104360NIMH NIH HHS P50 MH096972NIMH NIH HHS R01 MH094527NIMH NIH HHS R01 MH094604NIMH NIH HHS T32 MH016434NIMH NIH HHS T32 MH065215
6 · The paper itself

Abstract

background and purposeThe psychostimulant cocaine induces complex molecular, cellular and behavioural responses as a consequence of inhibiting presynaptic dopamine, noradrenaline and 5-HT transporters. To elucidate 5-HT transporter (SERT)-specific contributions to cocaine action, we evaluated cocaine effects in the SERT Met172 knock-in mouse, which expresses a SERT coding substitution that eliminates high-affinity cocaine recognition. EXPERIMENTAL APPROACH: We measured the effects of SERT Met172 on cocaine antagonism of 5-HT re-uptake using ex vivo synaptosome preparations and in vivo microdialysis. We assessed SERT dependence of cocaine actions behaviourally through acute and chronic locomotor activation, sensitization, conditioned place preference (CPP) and oral cocaine consumption. We used c-Fos, quantitative RT-PCR and RNA sequencing methods for insights into cellular and molecular networks supporting SERT-dependent cocaine actions. KEY

resultsSERT Met172 mice demonstrated functional insensitivity for cocaine at SERT. Although they displayed wild-type levels of acute cocaine-induced hyperactivity or chronic sensitization, the pattern of acute motor activation was different, with a bias toward thigmotaxis. CPP was increased, and a time-dependent elevation in oral cocaine consumption was observed. SERT Met172 mice displayed relatively higher levels of neuronal activation in the hippocampus, piriform cortex and prelimbic cortex (PrL), accompanied by region-dependent changes in immediate early gene expression. Distinct SERT-dependent gene expression networks triggered by acute and chronic cocaine administration were identified, including PrL Akt and nucleus accumbens ERK1/2 signalling. CONCLUSION AND IMPLICATIONS: Our studies reveal distinct SERT contributions to cocaine action, reinforcing the possibility of targeting specific aspects of cocaine addiction by modulation of 5-HT signalling.

Indexed as

AnimalsCentral Nervous System StimulantsCocaineCocaine-Related DisordersConditioning, PsychologicalFemaleHippocampusMaleMiceMotor ActivityNeuronsNucleus AccumbensPrefrontal CortexProto-Oncogene Proteins c-fosSerotoninSerotonin Plasma Membrane Transport ProteinsCentral Nervous System StimulantsCocaineProto-Oncogene Proteins c-fosSerotoninSerotonin Plasma Membrane Transport Proteins

Identifiers

PMID28585320
PMCPMC5522997
OpenAlexW2624443697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.